Innovation. Clarity. Execution.  I  Portfolio

Portfolio.

Life-changing innovation

The companies in which we have invested since the year 2006 have discovered and developed, fifteen approved medicines and products to the benefit of patients, physicians and our investors.

View and filter our portfolio below

Filter

Image
Centessa

Centessa

Share sale
Image
Acutus

Acutus

Cardiac mapping system for AF
Image
Acutus

Acutus

IPO NASDAQ
Image
Agenus

Agenus

Broad immunotherapy platform for cancer
Image
ALETA

ALETA

Transformative adoptive cell therapy
Image
Algeta

Algeta

Alpha-emitter anticancer agents
Image
AlphaRose Therapeutics

AlphaRose Therapeutics

Revolutionizing Precision Medicine For Patients. By Patients.
Image
Amphista

Amphista

Targeted Protein Degradation
Image
Aravive

Aravive

Therapies targeting survival pathways for cancer
Image
Argá Medtech

Argá Medtech

Next Generation Cardiac Ablation
Image
Arrakis

Arrakis

Small molecule modulators of RNA
Image
Artax

Artax

Novel therapy for autoimmune disease
Image
Aura

Aura

Novel therapies for ocular cancers
Image
AviadoBio

AviadoBio

Revolution in gene therapy for neurodegenerative disorders
Image
Avila

Avila

Covalent small molecule platform
Image
Axonics

Axonics

Novel sacral neuromodulation system
Image
Beacon

Beacon

Transform lives with pioneering ocular gene therapy
Image
Biocartis

Biocartis

Molecular diagnostics platform
Image
CardiacAssist

CardiacAssist

Alpha-emitter anticancer agents
Image
CardiAQ

CardiAQ

Novel device for mitral valve replacement
Image
Cardiokine

Cardiokine

Cardio-renal drug development
Image
Cellnovo

Cellnovo

Micro insulin pump with connectivity
Image
Centessa

Centessa

Novel asset-centric pharmaceutical company
Image
CN

CN

Nicotine replacement e-cigarette
Image
Conatus

Conatus

Therapeutics for liver disease
Image
Curve

Curve

Next-gen functional discovery platform
Image
Eloxx

Eloxx

Ribosome Modulating Agents for Rare Disease
Image
Emergent

Emergent

Innovative vaccines and therapeutics
Image
Epitopea

Epitopea

Next generation immunotherapies
Image
EUSA

EUSA

Trans-Atlantic specialty pharma company
Image
F2G

F2G

Novel anti-fungal therapy
Image
Glycomine

Glycomine

Developing Substrate Replacement Therapies
Image
Highlight

Highlight

Bridging the innate to adaptive immune response
Image
Infinity

Infinity

Chemical genomic-based drug discovery
Image
Iterum

Iterum

Novel oral antibiotic
Image
Kandy

Kandy

Therapeutics for Women’s Health
Image
KuDos

KuDos

DNA damage repair therapy
Image
Levicept

Levicept

Novel pain treatment for osteoarthritis
Image
Micromet

Micromet

Bi-specific antibodies
Image
MiroBio

MiroBio

Immune cell regulation
Image
Moximed

Moximed

Novel device for treating osteoarthritis of the knee
Image
Nalu

Nalu

Novel spinal cord stimulation device
Image
NeRRe

NeRRe

Pipeline of neurokinin antagonists
Image
Orphalan

Orphalan

Rare disease company
Image
Pheno

Pheno

Remyelinating therapy development
Image
PIC

PIC

Targeting oncogene translation
Image
PowderMed

PowderMed

Needle-free vaccine delivery
Image
Proximie

Proximie

Best-in-class technology for connected surgical care
Image
Rappta

Rappta

Novel PP2A activators to treat cancer
Image
Relief Cardiovascular

Relief Cardiovascular

Pioneering device for diuretic resistant heart failure
Image
Respivert

Respivert

Novel therapies for respiratory disorders
Image
Santarus

Santarus

Speciality pharmaceuticals
Image
SEP

SEP

European pharma focused on urology
Image
Thiakis

Thiakis

Novel hormone treatment for obesity
Image
Tridek-One

Tridek-One

Novel approach for treatment of vasculitis
Image
UniQure

UniQure

Gene therapy for rare disease
Image
Ventus

Ventus

Innovative smoking cessation products

About

Leading Venture Investors
Learn More

Exit History

View Our Exit History
Learn More